• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Terns Pharmaceuticals, Inc. - Common Stock (NQ:TERN)

    7.810 +0.300 (+3.99%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,169,292
    Open 7.520
    Bid (Size) 7.640 (3)
    Ask (Size) 8.000 (1)
    Prev. Close 7.510
    Today's Range 7.450 - 8.090
    52wk Range 1.865 - 9.000
    Shares Outstanding 61,071,897
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    2 Under-the-Radar Stocks That Could Soar
    They could ride the wave of the hottest therapeutic area in the industry. 
    Via The Motley Fool
    Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025
    Webinar to be held on Wednesday, September 3, 2025 at 4:30 p.m. ET 
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +37.7%
    +37.7%
    1 Month
    +3.3%
    +3.3%
    3 Month
    +102.9%
    +102.9%
    6 Month
    +205.1%
    +205.1%
    1 Year
    -6.4%
    -6.4%

    More News

    Read More
    Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
    Via MarketMinute
    Topics Economy
    Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
    Via Benzinga
    Terns (TERN) Q2 Net Loss Narrows 16%
    Via The Motley Fool
    Topics Intellectual Property
    Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street
    Via The Motley Fool
    Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Terns Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Terns Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Terns Pharmaceuticals, Inc. - Common Stock trade on?
    Terns Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Terns Pharmaceuticals, Inc. - Common Stock is TERN on the Nasdaq Stock Market
    What is the current price of Terns Pharmaceuticals, Inc. - Common Stock?
    The current price of Terns Pharmaceuticals, Inc. - Common Stock is 7.810
    When was Terns Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Terns Pharmaceuticals, Inc. - Common Stock was at 10/01/25 04:00 PM ET
    What is the market capitalization of Terns Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Terns Pharmaceuticals, Inc. - Common Stock is 476.97M
    How many shares of Terns Pharmaceuticals, Inc. - Common Stock are outstanding?
    Terns Pharmaceuticals, Inc. - Common Stock has 477M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.